Literature DB >> 15632290

The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK.

Iveta Bártová1, Michal Otyepka, Zdenek Kríz, Jaroslav Koca.   

Abstract

Molecular dynamics (MD) simulations were used to explain structural details of cyclin-dependent kinase-2 (CDK2) inhibition by phosphorylation at T14 and/or Y15 located in the glycine-rich loop (G-loop). Ten-nanosecond-long simulations of fully active CDK2 in a complex with a short peptide (HHASPRK) substrate and of CDK2 inhibited by phosphorylation of T14 and/or Y15 were produced. The inhibitory phosphorylations at T14 and/or Y15 show namely an ATP misalignment and a G-loop shift (~5 A) causing the opening of the substrate binding box. The biological functions of the G-loop and GxGxxG motif evolutionary conservation in protein kinases are discussed. The position of the ATP gamma-phosphate relative to the phosphorylation site (S/T) of the peptide substrate in the active CDK2 is described and compared with inhibited forms of CDK2. The MD results clearly provide an explanation previously not known as to why a basic residue (R/K) is preferred at the P(2) position in phosphorylated S/T peptide substrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632290      PMCID: PMC2253414          DOI: 10.1110/ps.04959705

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  22 in total

Review 1.  Dynamics of cAMP-dependent protein kinase.

Authors:  D A Johnson; P Akamine; E Radzio-Andzelm; M Madhusudan; S S Taylor
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

Review 2.  Structural basis for control by phosphorylation.

Authors:  L N Johnson; R J Lewis
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

Review 3.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

4.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.

Authors:  N R Brown; M E Noble; J A Endicott; L N Johnson
Journal:  Nat Cell Biol       Date:  1999-11       Impact factor: 28.824

5.  Docking-based development of purine-like inhibitors of cyclin-dependent kinase-2.

Authors:  M Otyepka; V Krystof; L Havlícek; V Siglerová; M Strnad; J Koca
Journal:  J Med Chem       Date:  2000-06-29       Impact factor: 7.446

6.  Structural studies on phospho-CDK2/cyclin A bound to nitrate, a transition state analogue: implications for the protein kinase mechanism.

Authors:  A Cook; E D Lowe; E D Chrysina; V T Skamnaki; N G Oikonomakos; L N Johnson
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

Review 7.  Cyclin-dependent kinases: inhibition and substrate recognition.

Authors:  J A Endicott; M E Noble; J A Tucker
Journal:  Curr Opin Struct Biol       Date:  1999-12       Impact factor: 6.809

8.  Dynamics and binding modes of free cdk2 and its two complexes with inhibitors studied by computer simulations.

Authors:  Michal Otyepka; Zdenek Kríz; Jaroslav Koca
Journal:  J Biomol Struct Dyn       Date:  2002-10

Review 9.  Structure-based design of cyclin-dependent kinase inhibitors.

Authors:  Thomas G Davies; David J Pratt; Jane A Endicott; Louise N Johnson; Martin E M Noble
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

Review 10.  Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials.

Authors:  Laurent Meijer; Eric Raymond
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

View more
  15 in total

1.  The effect of Li+ on GSK-3 inhibition: molecular dynamics simulation.

Authors:  Hao Sun; Yong-jun Jiang; Qing-sen Yu; Cheng-cai Luo; Jian-wei Zou
Journal:  J Mol Model       Date:  2010-05-16       Impact factor: 1.810

2.  A molecular mechanism of P-loop pliability of Rho-kinase investigated by molecular dynamic simulation.

Authors:  Keigo Gohda; Toshio Hakoshima
Journal:  J Comput Aided Mol Des       Date:  2008-04-15       Impact factor: 3.686

3.  Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.

Authors:  Bing Zhang; Vincent B C Tan; Kian Meng Lim; Tong Earn Tay; Shulin Zhuang
Journal:  J Mol Model       Date:  2006-06-13       Impact factor: 1.810

4.  Molecular dynamics simulations on the inhibition of cyclin-dependent kinases 2 and 5 in the presence of activators.

Authors:  Bing Zhang; Vincent B C Tan; Kian Meng Lim; Tong Earn Tay
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

5.  Regulatory phosphorylation of cyclin-dependent kinase 2: insights from molecular dynamics simulations.

Authors:  Iveta Bártová; Jaroslav Koca; Michal Otyepka
Journal:  J Mol Model       Date:  2008-05-10       Impact factor: 1.810

6.  Two C-terminal ankyrin repeats form the minimal stable unit of the ankyrin repeat protein p18INK4c.

Authors:  Petr Sklenovský; Pavel Banás; Michal Otyepka
Journal:  J Mol Model       Date:  2008-05-15       Impact factor: 1.810

7.  Functional flexibility of human cyclin-dependent kinase-2 and its evolutionary conservation.

Authors:  Iveta Bártová; Jaroslav Koca; Michal Otyepka
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

8.  A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding.

Authors:  Emma S Child; Tereza Hendrychová; Karen McCague; Andy Futreal; Michal Otyepka; David J Mann
Journal:  Biochim Biophys Acta       Date:  2010-04-24

9.  Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study.

Authors:  Hai-Xiao Jin; Mei-Lin Go; Peng Yin; Xiao-Ting Qiu; Peng Zhu; Xiao-Jun Yan
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

10.  Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.

Authors:  Soumya Lipsa Rath; Sanjib Senapati
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.